NPI: 1629335864 · PEMBROKE PINES, FL 33026 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/12/2012
Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | WINSTEL, JOHN (CHIEF ACCOUNTING OFFICER) |
| NPI Enumeration Date | 04/12/2012 |
Other providers sharing the same authorized official: WINSTEL, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 13,104 | $1.40M |
| 2019 | 13,591 | $1.46M |
| 2020 | 21,256 | $2.95M |
| 2021 | 21,020 | $1.68M |
| 2022 | 15,401 | $1.53M |
| 2023 | 1,035 | $149K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 24,160 | 1,494 | $2.87M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 27,371 | 1,187 | $2.79M |
| J1270 | Injection, doxercalciferol, 1 mcg | 15,623 | 966 | $1.67M |
| A4657 | Syringe, with or without needle, each | 2,755 | 1,247 | $375K |
| J1756 | Injection, iron sucrose, 1 mg | 4,833 | 763 | $361K |
| 83550 | 1,655 | 993 | $168K | |
| 85048 | 1,739 | 1,047 | $168K | |
| 85041 | 1,739 | 1,048 | $168K | |
| 83540 | 1,654 | 992 | $167K | |
| 83970 | 1,356 | 776 | $152K | |
| 82728 | 1,433 | 855 | $148K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 560 | 358 | $63K |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 277 | 111 | $25K |
| 82108 | 139 | 92 | $14K | |
| 82607 | 63 | 42 | $7K | |
| 90674 | 21 | 12 | $4K | |
| G0008 | Administration of influenza virus vaccine | 14 | 12 | $3K |
| 82746 | 15 | 12 | $2K |